Works matching IS 22965270 AND DT 2017 AND VI 40
Results: 243
Family-Oriented Rehabilitation (FOR) and Rehabilitation of Adolescents and Young Adults (AYA) in Pediatric Oncology.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 12, p. 752, doi. 10.1159/000484609
- By:
- Publication type:
- Article
Adjuvant Radiotherapy in High-Risk Squamous Cell Carcinoma of the Vulva: A Two-Institutional Italian Experience.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 12, p. 778, doi. 10.1159/000479876
- By:
- Publication type:
- Article
Oncological Rehabilitation and Cancer Survivorship.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 12, p. 744, doi. 10.1159/000485188
- By:
- Publication type:
- Article
Rehabilitation of Cancer Survivors with Long-Term Toxicities.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 12, p. 764, doi. 10.1159/000485187
- By:
- Publication type:
- Article
Return to Work of Cancer Survivors.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 12, p. 760, doi. 10.1159/000485079
- By:
- Publication type:
- Article
The Functional Assessment of Chronic Illness Therapy -- Fatigue (FACIT-Fatigue Subscale): Validity and Reliability of the Iranian Version.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 12, p. 789, doi. 10.1159/000479588
- By:
- Publication type:
- Article
Successful Evidence-Based Treatment of Patients with Advanced Pancreatic Cancer in Community-Based Oncology Group Practices.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 12, p. 784, doi. 10.1159/000480016
- By:
- Publication type:
- Article
Late Effects and Long-Term Follow-Up after Cancer in Childhood.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 12, p. 746, doi. 10.1159/000484936
- By:
- Publication type:
- Article
Oncological Rehabilitation.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 12, p. 772, doi. 10.1159/000481709
- By:
- Publication type:
- Article
Ixazomib (NINLARO®): Wirksamkeit im Praxisalltag beim multiplen Myelom.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 11, p. 731
- Publication type:
- Article
Avastin: Feste Säule in der Therapie des NSCLC.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 11, p. 731
- Publication type:
- Article
Letermovir in Phase-III-Studie erfolgreich - Antrag auf Zulassung eingereicht.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 11, p. 731
- Publication type:
- Article
Phase-III-Studie CheckMate-214 vorzeitig beendet: Nivolumab in Kombination mit Ipilimumab zeigt Gesamtüberlebensvorteil bei Patienten mit bisher unbehandeltem fortgeschrittenem oder metastasiertem Nierenzellkarzinom.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 11, p. 731
- Publication type:
- Article
CDK4/6-Inhibitoren als Wirkverstärker der endokrinen Therapie.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 11, p. 731
- By:
- Publication type:
- Article
Im Gespräch mit Dr. Terheyden: Herausforderungen und Perspektiven beim Merkelzellkarzinom.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 11, p. 731
- Publication type:
- Article
Avelumab: Erste speziell für das Merkelzellkarzinom zugelassene medikamentöse Therapie.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 11, p. 731
- By:
- Publication type:
- Article
Hohe Remissionsraten mit Inotuzumab Ozogamicin (Besponsa®).
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 11, p. 731
- By:
- Publication type:
- Article
5 Jahre Erfahrung mit dem 5-Tages-Regime.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 11, p. 731, doi. 10.1159/000484308
- Publication type:
- Article
Rezidivrisiko langfristig minimiert.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 11, p. 731, doi. 10.1159/000484307
- By:
- Publication type:
- Article
José Carreras-Forschungsstipendien an drei Nachwuchs-Wissenschaftler.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 11, p. 717
- Publication type:
- Article
Monatsthema im November: Klinische Studien in der Krebstherapie - Informationen für Patienten.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 11, p. 716
- Publication type:
- Article
DVO ebnet Weg für osteologischen Nachwuchs: Startschuss für neues Zertifizierungsmodell fällt im Dezember 2017.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 11, p. 714
- Publication type:
- Article
Pro und Contra Methadon als Krebsmedikament: Ohne weitere klinische Studien ist der Einsatz bei Patienten nicht vertretbar.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 11, p. 713
- Publication type:
- Article
Jahrestagung 2017: Fachgesellschaften für stärkere Förderung akademischer Forschung.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 11, p. 711
- Publication type:
- Article
Circulating Cell-Free DNA Levels in Patients with Metastatic Renal Cell Carcinoma.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 11, p. 707, doi. 10.1159/000479523
- By:
- Publication type:
- Article
Evidence for an Association of ERCC1 Expression and Mismatch Repair Status with Overall Survival in Colorectal Cancer Patients.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 11, p. 702, doi. 10.1159/000479068
- By:
- Publication type:
- Article
Definitive Radiotherapy for Primary Squamous Cell Carcinoma of the Vagina: Are High-Dose External Beam Radiotherapy and High-Dose-Rate Brachytherapy Boost the Best Treatment? Experience of Two Italian Institutes.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 11, p. 697, doi. 10.1159/000480350
- By:
- Publication type:
- Article
Specific Adoptive Cellular Immunotherapy in Allogeneic Stem Cell Transplantation.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 11, p. 691, doi. 10.1159/000484051
- By:
- Publication type:
- Article
Wilms' Tumor Gene 1 (WT1) Peptide Vaccine Therapy for Hematological Malignancies: From CTL Epitope Identification to Recent Progress in Clinical Studies Including a Cure-Oriented Strategy.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 11, p. 682, doi. 10.1159/000481353
- By:
- Publication type:
- Article
Cellular Immunotherapy in B-Cell Malignancy.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 11, p. 674, doi. 10.1159/000481946
- By:
- Publication type:
- Article
Handfeste Optionen bei EGFR-Mutationen.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 637
- By:
- Publication type:
- Article
Checkpoint Inhibition in Non-Hodgkin's Lymphoma.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 11, p. 662, doi. 10.1159/000481888
- By:
- Publication type:
- Article
Immune Therapy of Lympho-Hemopoietic Malignancies.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 11, p. 652, doi. 10.1159/000484052
- By:
- Publication type:
- Article
EU-Zulassung für Kisqali® (Ribociclib) als Erstlinientherapie des HR+/HER2-, lokal fortgeschrittenen oder metastasierten Mammakarzinoms erhalten.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 638
- Publication type:
- Article
Schlüssel zur CLL-Primärtherapie?
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 638
- Publication type:
- Article
Das Multiple Myelom besser verstehen -- drei Erklärfilme für Patienten und Angehörige ab sofort online.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 637
- Publication type:
- Article
Checkpoint Inhibition in Hodgkin Lymphoma - a Review.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 11, p. 654, doi. 10.1159/000481800
- By:
- Publication type:
- Article
Osimertinib verbessert das progressionsfreie Überleben bei Lungenkrebs signifikant und klinisch relevant.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 636
- Publication type:
- Article
Zweite Phase-III-Studie zeigt signifikant verlängertes Gesamtüberleben von Patienten mit rezidiviertem multiplem Myelom unter einem Carfilzomib (Kyprolis®)-Behandlungsregime.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 636
- Publication type:
- Article
Erstes Rituximab-Biosimilar ermöglicht sichere und qualitativ hochwertige Behandlung von B-Zell-Lymphomen.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 629, doi. 10.1159/000481598
- By:
- Publication type:
- Article
«Wir wollen die Forschung in der Immunonkologie beschleunigen und Patienten eine individuell zugeschnittene Therapie ermöglichen».
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 635
- By:
- Publication type:
- Article
Heilungschancen bei APL durch Therapie der Koagulopathie weiter verbessern.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 636
- By:
- Publication type:
- Article
Praktische Erfahrungen mit Kadcyla®▼ in der Therapie von Patientinnen mit HER2- und Hormonrezeptor-positivem Mammakarzinom.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 633
- By:
- Publication type:
- Article
Darzalex®: Neuer Standard in der Zweitlinientherapie.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 631, doi. 10.1159/000481599
- Publication type:
- Article
Daten zum Wirkmechanismus liefern Ansatzpunkte für weitere Einsatzmöglichkeiten.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 628, doi. 10.1159/000481597
- By:
- Publication type:
- Article
Neues aus der ersten Jahreshälfte 2017.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 634
- By:
- Publication type:
- Article
23. José Carreras Gala in München.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 627
- Publication type:
- Article
Monatsthema im Oktober: Mobile Helfer - Können Apps bei Vorsorge und Krebstherapie unterstützen?
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 626
- Publication type:
- Article
Methadon in der Krebstherapie: Hohe Erwartungen können nicht erfüllt werden.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 625
- Publication type:
- Article
In 4 Jahren vom 'Breakthrough of the year' bis zur ersten Zulassung: Die Hämatologie und Onkologie bleibt ein extrem innovatives Fachgebiet.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 623
- Publication type:
- Article